N-acetylation in healthy and diseased children
- PMID: 2276387
- DOI: 10.1007/BF02657055
N-acetylation in healthy and diseased children
Abstract
Acetylation capacity was examined in three groups of Czech children by measuring the plasma and urine concentrations of sulphamethazine and its acetylated metabolite 6 h after an oral test dose of 20 mg/kg sulphamethazine. Amongst 82 healthy children aged 4-15 y there were 32 (39%) fast acetylators; there was no significant difference between the number of boys and girls, or between children over or less than 6 years of age. In 41 patients aged 3-15 y with phenylketonuria, the acetylation indices showed a significantly higher proportion of fast acetylators - 24 (58.5%) using plasma measurements and 29 (70.7%) using urine data. In them the ratio between slow and fast acetylators was inverted compared to normal children. The preponderance of fast acetylators was greater in boys than in girls and in children over 6 years of age. An increased acetylation capacity in patients with phenylketonuria was apparent even in individuals classified as slow acetylators, because in them the plasma concentration of the acetylated metabolite was higher than in control acetylators. Amongst 48 young patients (5-15 y) with insulin-dependent diabetes there were 19 (39.6%) fast and 29 (60.4%) slow acetylators, which corresponded well to the phenotype distribution in control children. This did not support the suggested association between the fast acetylator phenotype and Type I diabetes.
Similar articles
-
Relationship between acetylator phenotype and intensity of the hypoglycaemic effect of a suplhonamide preparation in children with insulin-dependent diabetes.Bratisl Lek Listy. 1991 Dec;92(12):609-14. Bratisl Lek Listy. 1991. PMID: 1806177
-
N-acetylation phenotyping with sulphadimidine in a Turkish population.Eur J Clin Pharmacol. 1990;38(1):53-6. doi: 10.1007/BF00314803. Eur J Clin Pharmacol. 1990. PMID: 2328748
-
Genetically determined variability in acetylation and oxidation. Therapeutic implications.Drugs. 1985 Apr;29(4):342-75. doi: 10.2165/00003495-198529040-00003. Drugs. 1985. PMID: 2859977 Review.
-
Association of microalbuminuria with slow acetylator phenotype in type 1 diabetes mellitus.Child Nephrol Urol. 1992;12(4):192-6. Child Nephrol Urol. 1992. PMID: 1473091
-
Survey of the human acetylator polymorphism in spontaneous disorders.J Med Genet. 1984 Aug;21(4):243-53. doi: 10.1136/jmg.21.4.243. J Med Genet. 1984. PMID: 6387123 Free PMC article. Review.
Cited by
-
Acetylator phenotypes of Jordanian diabetics.Eur J Clin Pharmacol. 1992;43(6):621-3. doi: 10.1007/BF02284960. Eur J Clin Pharmacol. 1992. PMID: 1493843
-
Comparison of CYP1A2 and NAT2 phenotypes between black and white smokers.Biochem Pharmacol. 2008 Oct 1;76(7):929-37. doi: 10.1016/j.bcp.2008.07.024. Epub 2008 Jul 25. Biochem Pharmacol. 2008. PMID: 18703023 Free PMC article. Clinical Trial.
-
Phenotype and genotype for thiopurine methyltransferase activity in the French Caucasian population: impact of age.Eur J Clin Pharmacol. 2004 Apr;60(2):89-96. doi: 10.1007/s00228-004-0732-5. Epub 2004 Mar 12. Eur J Clin Pharmacol. 2004. PMID: 15022030
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical